PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 2112565
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 2112565
Metagenomic Sequencing Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2026 - 2032)
The global metagenomic sequencing market was valued at USD 2.8 billion in 2025 and is projected to reach USD 10.1 billion by 2032, growing at a CAGR of 20.1% between 2026 and 2032. Growth is being driven by falling next-generation sequencing costs and the maturation of shotgun and long-read platforms, as culture-independent methods increasingly characterize complex microbial communities directly from clinical and environmental samples.
The diagnostic advantage is significant. Metagenomic sequencing enables hypothesis-free detection of bacteria, viruses, fungi, and parasites in a single assay, accelerating diagnosis of infections that evade traditional culture, since more than 99% of environmental microorganisms are estimated to be unculturable, according to studies published by the NCBI.
Sustained public investment reinforces this trajectory. The U.S. National Institutes of Health's Common Fund invested approximately USD 215 million in the Human Microbiome Project, generating reference datasets and computational tools that have advanced commercial metagenomics workflows.
Key Insights
Drug Discovery is the largest application at 35% share, driven by pharmaceutical research through industry-academic collaborations. Clinical Diagnostics posts the highest CAGR, at approximately 20.6%, as untargeted metagenomic sequencing identifies pathogens where conventional culture or PCR testing fails.
Sequencing holds the largest workflow share at 60%, central to generating microbial genomic data; Illumina launched the MiSeq i100 Series in October 2024, a compact benchtop platform delivering results in approximately four hours, four times faster than the previous system. Data Processing & Analysis posts the highest CAGR, as sequencing throughput increases and laboratories require advanced bioinformatics for taxonomic classification.
Shotgun Metagenomic Sequencing holds both the largest and fastest-growing technology share, at approximately 20.8% CAGR, allowing complete reading of all genomes within a DNA molecule; Delve Bio partnered with Broad Clinical Labs in October 2024 to provide clinical mNGS services for infectious disease diagnostics.
Reagents and Consumables hold the largest offering share, at 45%, generating recurring revenue tied to sample throughput. Services post the highest CAGR, driven by outsourcing demand from pharmaceutical and biotechnology users seeking end-to-end support without building in-house platforms.
North America holds the largest regional share, at 40%, driven by substantial R&D activity and robust support for new research facilities. The NIH received an appropriation of approximately USD 47.7 billion, reinforcing the region's leadership in sequencing research.
Asia-Pacific posts the highest regional CAGR, at approximately 21.0%, driven by increasing genomics investments and expanding healthcare infrastructure across the region.
Clinical diagnostics integration is a defining trend, as metagenomic sequencing moves from research tool to clinical modality. The CDC launched its Next-Generation Sequencing Quality Initiative in 2024, providing standardized practices to improve NGS-based testing reliability across clinical laboratories.
Rising antimicrobial resistance burden remains the biggest driver. A systematic analysis published in The Lancet estimated that bacterial AMR was directly responsible for 1.27 million deaths and associated with 4.95 million deaths worldwide in 2019, establishing it as a leading global public health threat.
Data interpretation complexity and standardization gaps are the main restraint, as converting raw sequence data into actionable conclusions requires specialized bioinformatics expertise many laboratories lack. The WHO's Global Genomic Surveillance Strategy 2022-2032 identified limited bioinformatics capacity as a key barrier to expanding genomic surveillance.
Microbiome therapeutics and agricultural genomics present a clear opportunity, as pharmaceutical companies explore uncultured microbial communities for novel drug candidates. The FDA approved the first microbiota-based live biotherapeutic products, Rebyota in 2022 and Vowst in 2023, for preventing recurrent Clostridioides difficile infection.
The competitive landscape spans sequencing platform providers, reagent manufacturers, and bioinformatics companies serving diverse clinical and research applications. Recent activity includes ALS Limited's launch of a Gut Microbiome Sequencing service offering end-to-end human and animal gut microbiome analysis, and continued expansion of clinical mNGS partnerships supporting infectious disease diagnostics across major reference laboratories.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market Size Breakdown, by Application
- 1.4.2. Market Size Breakdown, by Workflow
- 1.4.3. Market Size Breakdown, by Technology
- 1.4.4. Market Size Breakdown, by Offering
- 1.4.5. Market Size Breakdown, by Region
- 1.4.6. Market Size Breakdown, by Country
- 1.5. Market Data Reporting Unit
- 1.5.1. Revenue
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence Database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Industry Background
- 5.2. Market Dynamics
- 5.2.1. Trends
- 5.2.2. Drivers
- 5.2.3. Restraints/Challenges
- 5.2.4. Emerging Economies and Key Opportunities
- 5.2.5. Impact Analysis of Drivers/Restraints
- 5.3. Sociopolitical Impact
- 5.4. Porter's Five Forces Analysis
- 5.4.1. Bargaining Power of Buyers
- 5.4.2. Bargaining Power of Suppliers
- 5.4.3. Threat of New Entrants
- 5.4.4. Intensity of Rivalry
- 5.4.5. Threat of Substitutes
- 5.5. Lifecycle Analysis
- 5.6. Innovation and Technology Trends
- 5.7. Economic and Regulatory Impact
- 5.8. Market Entry Strategies
Chapter 6. Competitive Landscape
- 6.1. List of Market Players and their Offerings
- 6.2. Market Share of Key Players (2025)
- 6.2.1. Global
- 6.2.2. North America
- 6.2.3. Europe
- 6.2.4. Asia-Pacific
- 6.2.5. Latin America
- 6.2.6. Middle East and Africa
- 6.3. Competitive Benchmarking of Key Players
- 6.4. Product Benchmarking of Key Players
- 6.5. Recent Strategic Developments by Key Players
- 6.6. Company Leadership Matrix
Chapter 7. Global Market
- 7.1. Overview
- 7.2. Market Revenue, by Application (2021-2032)
- 7.3. Market Revenue, by Workflow (2021-2032)
- 7.4. Market Revenue, by Technology (2021-2032)
- 7.5. Market Revenue, by Offering (2021-2032)
- 7.6. Market Revenue, by Region (2021-2032)
Chapter 8. North America Market
- 8.1. Overview
- 8.2. Market Revenue, by Application (2021-2032)
- 8.3. Market Revenue, by Workflow (2021-2032)
- 8.4. Market Revenue, by Technology (2021-2032)
- 8.5. Market Revenue, by Offering (2021-2032)
- 8.6. Market Revenue, by Country (2021-2032)
Chapter 9. Europe Market
- 9.1. Overview
- 9.2. Market Revenue, by Application (2021-2032)
- 9.3. Market Revenue, by Workflow (2021-2032)
- 9.4. Market Revenue, by Technology (2021-2032)
- 9.5. Market Revenue, by Offering (2021-2032)
- 9.6. Market Revenue, by Country (2021-2032)
Chapter 10. Asia-Pacific Market
- 10.1. Overview
- 10.2. Market Revenue, by Application (2021-2032)
- 10.3. Market Revenue, by Workflow (2021-2032)
- 10.4. Market Revenue, by Technology (2021-2032)
- 10.5. Market Revenue, by Offering (2021-2032)
- 10.6. Market Revenue, by Country (2021-2032)
Chapter 11. Latin America Market
- 11.1. Overview
- 11.2. Market Revenue, by Application (2021-2032)
- 11.3. Market Revenue, by Workflow (2021-2032)
- 11.4. Market Revenue, by Technology (2021-2032)
- 11.5. Market Revenue, by Offering (2021-2032)
- 11.6. Market Revenue, by Country (2021-2032)
Chapter 12. Middle East and Africa Market
- 12.1. Overview
- 12.2. Market Revenue, by Application (2021-2032)
- 12.3. Market Revenue, by Workflow (2021-2032)
- 12.4. Market Revenue, by Technology (2021-2032)
- 12.5. Market Revenue, by Offering (2021-2032)
- 12.6. Market Revenue, by Country (2021-2032)
Chapter 13. U.S. Market
- 13.1. Overview
- 13.2. Economic Indicators
- 13.3. Demographics and Population Insights
- 13.4. Growth Drivers
- 13.5. Challenges and Barriers
- 13.6. Competitive Strategies
- 13.7. Emerging Players
- 13.8. Market Size and Forecast
- 13.8.1. Market Revenue, by Application (2021-2032)
- 13.8.2. Market Revenue, by Workflow (2021-2032)
- 13.8.3. Market Revenue, by Technology (2021-2032)
- 13.8.4. Market Revenue, by Offering (2021-2032)
Chapter 14. Canada Market
- 14.1. Overview
- 14.2. Economic Indicators
- 14.3. Demographics and Population Insights
- 14.4. Growth Drivers
- 14.5. Challenges and Barriers
- 14.6. Competitive Strategies
- 14.7. Emerging Players
- 14.8. Market Size and Forecast
- 14.8.1. Market Revenue, by Application (2021-2032)
- 14.8.2. Market Revenue, by Workflow (2021-2032)
- 14.8.3. Market Revenue, by Technology (2021-2032)
- 14.8.4. Market Revenue, by Offering (2021-2032)
Chapter 15. Germany Market
- 15.1. Overview
- 15.2. Economic Indicators
- 15.3. Demographics and Population Insights
- 15.4. Growth Drivers
- 15.5. Challenges and Barriers
- 15.6. Competitive Strategies
- 15.7. Emerging Players
- 15.8. Market Size and Forecast
- 15.8.1. Market Revenue, by Application (2021-2032)
- 15.8.2. Market Revenue, by Workflow (2021-2032)
- 15.8.3. Market Revenue, by Technology (2021-2032)
- 15.8.4. Market Revenue, by Offering (2021-2032)
Chapter 16. U.K. Market
- 16.1. Overview
- 16.2. Economic Indicators
- 16.3. Demographics and Population Insights
- 16.4. Growth Drivers
- 16.5. Challenges and Barriers
- 16.6. Competitive Strategies
- 16.7. Emerging Players
- 16.8. Market Size and Forecast
- 16.8.1. Market Revenue, by Application (2021-2032)
- 16.8.2. Market Revenue, by Workflow (2021-2032)
- 16.8.3. Market Revenue, by Technology (2021-2032)
- 16.8.4. Market Revenue, by Offering (2021-2032)
Chapter 17. France Market
- 17.1. Overview
- 17.2. Economic Indicators
- 17.3. Demographics and Population Insights
- 17.4. Growth Drivers
- 17.5. Challenges and Barriers
- 17.6. Competitive Strategies
- 17.7. Emerging Players
- 17.8. Market Size and Forecast
- 17.8.1. Market Revenue, by Application (2021-2032)
- 17.8.2. Market Revenue, by Workflow (2021-2032)
- 17.8.3. Market Revenue, by Technology (2021-2032)
- 17.8.4. Market Revenue, by Offering (2021-2032)
Chapter 18. Italy Market
- 18.1. Overview
- 18.2. Economic Indicators
- 18.3. Demographics and Population Insights
- 18.4. Growth Drivers
- 18.5. Challenges and Barriers
- 18.6. Competitive Strategies
- 18.7. Emerging Players
- 18.8. Market Size and Forecast
- 18.8.1. Market Revenue, by Application (2021-2032)
- 18.8.2. Market Revenue, by Workflow (2021-2032)
- 18.8.3. Market Revenue, by Technology (2021-2032)
- 18.8.4. Market Revenue, by Offering (2021-2032)
Chapter 19. Spain Market
- 19.1. Overview
- 19.2. Economic Indicators
- 19.3. Demographics and Population Insights
- 19.4. Growth Drivers
- 19.5. Challenges and Barriers
- 19.6. Competitive Strategies
- 19.7. Emerging Players
- 19.8. Market Size and Forecast
- 19.8.1. Market Revenue, by Application (2021-2032)
- 19.8.2. Market Revenue, by Workflow (2021-2032)
- 19.8.3. Market Revenue, by Technology (2021-2032)
- 19.8.4. Market Revenue, by Offering (2021-2032)
Chapter 20. China Market
- 20.1. Overview
- 20.2. Economic Indicators
- 20.3. Demographics and Population Insights
- 20.4. Growth Drivers
- 20.5. Challenges and Barriers
- 20.6. Competitive Strategies
- 20.7. Emerging Players
- 20.8. Market Size and Forecast
- 20.8.1. Market Revenue, by Application (2021-2032)
- 20.8.2. Market Revenue, by Workflow (2021-2032)
- 20.8.3. Market Revenue, by Technology (2021-2032)
- 20.8.4. Market Revenue, by Offering (2021-2032)
Chapter 21. India Market
- 21.1. Overview
- 21.2. Economic Indicators
- 21.3. Demographics and Population Insights
- 21.4. Growth Drivers
- 21.5. Challenges and Barriers
- 21.6. Competitive Strategies
- 21.7. Emerging Players
- 21.8. Market Size and Forecast
- 21.8.1. Market Revenue, by Application (2021-2032)
- 21.8.2. Market Revenue, by Workflow (2021-2032)
- 21.8.3. Market Revenue, by Technology (2021-2032)
- 21.8.4. Market Revenue, by Offering (2021-2032)
Chapter 22. Japan Market
- 22.1. Overview
- 22.2. Economic Indicators
- 22.3. Demographics and Population Insights
- 22.4. Growth Drivers
- 22.5. Challenges and Barriers
- 22.6. Competitive Strategies
- 22.7. Emerging Players
- 22.8. Market Size and Forecast
- 22.8.1. Market Revenue, by Application (2021-2032)
- 22.8.2. Market Revenue, by Workflow (2021-2032)
- 22.8.3. Market Revenue, by Technology (2021-2032)
- 22.8.4. Market Revenue, by Offering (2021-2032)
Chapter 23. South Korea Market
- 23.1. Overview
- 23.2. Economic Indicators
- 23.3. Demographics and Population Insights
- 23.4. Growth Drivers
- 23.5. Challenges and Barriers
- 23.6. Competitive Strategies
- 23.7. Emerging Players
- 23.8. Market Size and Forecast
- 23.8.1. Market Revenue, by Application (2021-2032)
- 23.8.2. Market Revenue, by Workflow (2021-2032)
- 23.8.3. Market Revenue, by Technology (2021-2032)
- 23.8.4. Market Revenue, by Offering (2021-2032)
Chapter 24. Australia Market
- 24.1. Overview
- 24.2. Economic Indicators
- 24.3. Demographics and Population Insights
- 24.4. Growth Drivers
- 24.5. Challenges and Barriers
- 24.6. Competitive Strategies
- 24.7. Emerging Players
- 24.8. Market Size and Forecast
- 24.8.1. Market Revenue, by Application (2021-2032)
- 24.8.2. Market Revenue, by Workflow (2021-2032)
- 24.8.3. Market Revenue, by Technology (2021-2032)
- 24.8.4. Market Revenue, by Offering (2021-2032)
Chapter 25. Brazil Market
- 25.1. Overview
- 25.2. Economic Indicators
- 25.3. Demographics and Population Insights
- 25.4. Growth Drivers
- 25.5. Challenges and Barriers
- 25.6. Competitive Strategies
- 25.7. Emerging Players
- 25.8. Market Size and Forecast
- 25.8.1. Market Revenue, by Application (2021-2032)
- 25.8.2. Market Revenue, by Workflow (2021-2032)
- 25.8.3. Market Revenue, by Technology (2021-2032)
- 25.8.4. Market Revenue, by Offering (2021-2032)
Chapter 26. Mexico Market
- 26.1. Overview
- 26.2. Economic Indicators
- 26.3. Demographics and Population Insights
- 26.4. Growth Drivers
- 26.5. Challenges and Barriers
- 26.6. Competitive Strategies
- 26.7. Emerging Players
- 26.8. Market Size and Forecast
- 26.8.1. Market Revenue, by Application (2021-2032)
- 26.8.2. Market Revenue, by Workflow (2021-2032)
- 26.8.3. Market Revenue, by Technology (2021-2032)
- 26.8.4. Market Revenue, by Offering (2021-2032)
Chapter 27. Saudi Arabia Market
- 27.1. Overview
- 27.2. Economic Indicators
- 27.3. Demographics and Population Insights
- 27.4. Growth Drivers
- 27.5. Challenges and Barriers
- 27.6. Competitive Strategies
- 27.7. Emerging Players
- 27.8. Market Size and Forecast
- 27.8.1. Market Revenue, by Application (2021-2032)
- 27.8.2. Market Revenue, by Workflow (2021-2032)
- 27.8.3. Market Revenue, by Technology (2021-2032)
- 27.8.4. Market Revenue, by Offering (2021-2032)
Chapter 28. South Africa Market
- 28.1. Overview
- 28.2. Economic Indicators
- 28.3. Demographics and Population Insights
- 28.4. Growth Drivers
- 28.5. Challenges and Barriers
- 28.6. Competitive Strategies
- 28.7. Emerging Players
- 28.8. Market Size and Forecast
- 28.8.1. Market Revenue, by Application (2021-2032)
- 28.8.2. Market Revenue, by Workflow (2021-2032)
- 28.8.3. Market Revenue, by Technology (2021-2032)
- 28.8.4. Market Revenue, by Offering (2021-2032)
Chapter 29. U.A.E. Market
- 29.1. Overview
- 29.2. Economic Indicators
- 29.3. Demographics and Population Insights
- 29.4. Growth Drivers
- 29.5. Challenges and Barriers
- 29.6. Competitive Strategies
- 29.7. Emerging Players
- 29.8. Market Size and Forecast
- 29.8.1. Market Revenue, by Application (2021-2032)
- 29.8.2. Market Revenue, by Workflow (2021-2032)
- 29.8.3. Market Revenue, by Technology (2021-2032)
- 29.8.4. Market Revenue, by Offering (2021-2032)
Chapter 30. Company Profiles
Chapter 31. Appendix
- 31.1. Sources and References
- 31.2. Related Reports
